Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medpace

308.88
-2.9900-0.96%
Post-market: 450.79141.91+45.94%19:59 EDT
Volume:1.12M
Turnover:361.15M
Market Cap:8.88B
PE:23.60
High:316.41
Open:313.36
Low:306.70
Close:311.87
Loading ...

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

StockStory
·
05 Mar

Medpace Holdings Insiders Sell US$187m Of Stock, Possibly Signalling Caution

Simply Wall St.
·
04 Mar

2 Reasons to Watch MEDP and 1 to Stay Cautious

StockStory
·
03 Mar

Shanghai MicuRx Pharmaceutical Sues Medpace Over Contract Dispute

MT Newswires Live
·
26 Feb

Here are the Reasons to Invest in Medpace Holdings (MEDP)

Insider Monkey
·
17 Feb

Medpace Holdings, Inc. (MEDP): A Bull Case Theory

Insider Monkey
·
14 Feb

Medpace Holdings: Strong Q4 Performance and Financial Health Justify Buy Rating Despite 2025 Challenges

TIPRANKS
·
13 Feb

Medpace Holdings Inc (MEDP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

GuruFocus.com
·
12 Feb

Q4 2024 Medpace Holdings Inc Earnings Call

Thomson Reuters StreetEvents
·
12 Feb

Medpace Reports Revenue and Income Growth in 2024

TIPRANKS
·
12 Feb

Why Medpace (MEDP) Shares Are Trading Lower Today

StockStory
·
12 Feb

Stock Track | Medpace Holdings Stock Plummets 7.21% on Analyst Hold Rating

Stock Track
·
11 Feb

Analysts’ Top Healthcare Picks: Incyte (INCY), Medpace Holdings (MEDP)

TIPRANKS
·
11 Feb

Truist Financial Keeps Their Hold Rating on Medpace Holdings (MEDP)

TIPRANKS
·
11 Feb

Medpace Stock Falls On Q4 Earnings: The Details

Benzinga
·
11 Feb

Medpace Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Feb

BRIEF-Medpace Holdings, Inc. Reports Fourth Quarter And Full Year 2024 Results

Reuters
·
11 Feb

Medpace: Q4 Earnings Snapshot

Associated Press Finance
·
11 Feb

Stock Track | Medpace stürzt 8,89 % nach Veröffentlichung solider Q4-Ergebnisse und verhaltener Jahresprognose ab

Stock Track
·
11 Feb

Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops

StockStory
·
11 Feb